ANDA 40461, held by Dr. Reddy's Laboratories. Mercaptopurine.
As of Nov 18, 2026, ANDA 40461 (Mercaptopurine), held by Dr. Reddy's Laboratories, was first approved by FDA on Feb 11, 2004, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 11, 2004 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Mercaptopurine50MG · tablet;oral | Mercaptopurine | Rx |
| Mar 8, 2013 | Supplement 6Labeling | Approved | None posted |
| May 18, 2005 | Supplement 2Labeling | Approved | None posted |
| Jan 28, 2005 | Supplement 1Labeling | Approved | None posted |
| Feb 11, 2004 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters